Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation. The gene discussed is CD19; the disease is precursor B-cell acute lymphoblastic leukemia.